The talent management and multi-media production company has enlisted MRC as its first disclosed corporate investor as it looks to expand into new business areas.

Existing investor Liberty Global Ventures contributed to a round that pushed the software deployment technology provider's total funding to at least $157m.

Existing investor Pasteur Mutualité came back for a round that will precede a trial of Volta's software, which helps in the treatment of cardiac arrythmias.

The antibody drug developer, majority owned by Luye Pharma, pushed its valuation past $850m in a round backed by Bank of China’s BOCG vehicle.

Microsoft, CSAA, Motorola Solutions and AAA-backed emergency response technology developer RapidSOS has secured $51.2m in new funding.

EV Growth took part in a $30m round for the robo-adviser developer, which had been acquired by Stockbit in early 2019.

Hanwha Systems has agreed to provide $30m in funding for the satellite technology provider, whose existing investors include Liberty Global and Intelsat.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Lilly Asia Ventures has put more funding into Transcenta to help sustain the antibody drug developer's clinical-stage pipeline.

AG Capital and Zenrin DataCom were among the backers that helped the mental health assessment software provider close an $11.8m round.